Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Stephen E. Rubenstein"'
Autor:
Maria R. Baer, Lori J. Maness, Judy H. Chiao, Donald P. Quick, Farhad Ravandi, Marc Buyse, Stephen A. Strickland, Selina M. Luger, Aleksandra Butrym, David F. Claxton, Pau Montesinos, Gary J. Schiller, Gianluca Gaidano, Karen Seiter, Daniel-Eric Robert, Jessica K. Altman, Hagop M. Kantarjian, Ellin Berman, Stephen E. Rubenstein, Martha Arellano, David A. Rizzieri, Marc Gautier, Xavier Thomas, Kebede H. Begna, Parameswaran Venugopal, Mikkael A. Sekeres, Tapan M. Kadia, Edward Agura, Stuart L. Goldberg, Yosr Hicheri, Janakiraman Subramanian, Scott R. Solomon
Publikováno v:
Blood. 130:891-891
Background: Sapacitabine is a novel oral nucleoside analogue with a unique ability to induce single-strand DNA breaks after incorporation into DNA, leading to production of double-strand DNA breaks and/or G2 cell cycle arrest. In AML cell lines, the
Autor:
Timothy Callahan, Stephen E. Rubenstein, Helen S. Pentikis, Donna Alvarez, Arthur C. Louie, Lawrence D. Mayer, Robert K. Stuart, Tara L. Lin, Laura C. Michaelis, Laura F. Newell
Publikováno v:
Blood. 126:2510-2510
Introduction: CPX-351 is a liposomal formulation of cytarabine and daunorubicin encapsulated at a fixed 5:1 molar ratio. It is highly effective in patients with high-risk acute myeloid leukemia (AML). This study evaluated the impact of CPX-351 (100 u